New targeted drugs for acute myeloid leukemia and antifungals: pharmacokinetic challenges and opportunities
We describe potential strategies to minimize the consequences of DDI between triazole antifungals and targeted therapies for acute myeloid leukemia and the role that collaboration between clinical pharmacologists, hematologists and clini cal or laboratory microbiologists may have in these settings.
Key Messages
Therapeutic drug monitoring and clinical pharmacology stewardship could represent two strategies that best express multidisciplinary collaboration for improving patient management.
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Fungal Infections | Hematology | Laboratory Medicine | Leukemia | Microbiology